A temporal correlation was found between Artemether-induced neuroprotection in insulted neurons and neurotherapeutic effects in the 3xTg-AD mouse model and stimulation of AMPK/GSK3β(ser9) phosphorylation activity and increased expression of activated Nrf2. Here, PRKAA2 is linked to Alzheimer disease.